ILLUMINATING ROUTES TO 3D ORGANOBORON MOLECULES
LUMIBOR aims to innovate sustainable drug design by leveraging boron hybridization and light-driven processes to create versatile 3D organoboron scaffolds for next-generation therapeutics.
Projectdetails
Introduction
With a steadily growing, aging population, there is significant strain on the pharmaceutical sector to produce state-of-the-art therapeutics for societal needs whilst respecting the finite resources provided by the environment.
Advances in Drug Design
Prominent advances in drug design are reliant on chemical synthesis platforms allowing the efficient exploration of chemical space to discover next-generation functional molecules. As a result, innovation is currently limited by the practical implementation of enabling methods, which often becomes the rate-limiting factor in cutting-edge research. This limitation is more pronounced when translating academic research to industrial settings.
Opportunity for Sustainability
The current renaissance of organic photochemistry and light-driven processes, in a broader sense, provides an opportunity to reconcile the growing demand for new functional molecules with consideration of sustainability and atom economy.
Project Overview: LUMIBOR
Inspired by the importance of organoboron motifs in medicinal chemistry, this EU action “LUMIBOR” will harness the untapped potential of boron hybridization and boron ligand design to unlock new excited state reactivity paradigms. This initiative aims to facilitate the discovery of new methods to access achiral and chiral 3D organoboron scaffolds.
Structural Platform Development
LUMIBOR will create a structural platform to utilize boron hybridization in the development of next-generation light-enabled ACTIVATION methods. Understanding the correlation between hybridization and parameters such as excited state energy and adjacent bond dissociation energy will allow access to synthetically versatile, high-energy intermediates such as:
- α-boryl radicals
- The triplet excited state
Strategic Control Over Reactivity
Strategic control over boron hybridization will also be utilized to regulate reactivity by influencing:
- Radical philicity
- Spin density
- Excited state lifetimes
- Other parameters
Conclusion
Collectively, LUMIBOR will create expansive guidelines to expand the synthesis arsenal by developing novel platforms to construct desirable 3D organoboron molecules.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.457.385 |
Totale projectbegroting | € 1.457.385 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Transforming Boron Chemistry By Exploring Boryl Radical ReactivityThis project aims to innovate organic chemistry by developing novel catalysis using boryl radicals for efficient C–B bond formation and new synthetic methods for complex molecules. | ERC Consolid... | € 1.999.250 | 2024 | Details |
Electrochemical Borylation via Borylene Species: Bridging a Gap in Synthetic ChemistryThis project aims to utilize electrochemistry for the controlled generation of borylenes, enabling novel borylation techniques and unlocking access to previously inaccessible molecular structures. | ERC Starting... | € 1.499.643 | 2024 | Details |
Large-Scale Electrosynthesis of Borylated AzinesB-ELECTRO aims to develop scalable methods for synthesizing borylated azines for use in Suzuki-Miyaura cross-coupling, enhancing pharmaceutical and agrochemical innovation. | ERC Proof of... | € 150.000 | 2024 | Details |
Reprogramming the reactivity of main-group compounds for capturing and activating methane and dinitrogenThe B-yond project aims to develop innovative main-group catalysts for unprecedented chemical transformations, advancing C-H bond functionalization and dinitrogen activation without transition metals. | ERC Consolid... | € 1.957.875 | 2022 | Details |
Next Generation Chiral Fluorine Groups for Molecular DesignThe project aims to develop sustainable fluorinated motifs using an organocatalytic platform to address environmental concerns while expanding chemical discovery in compliance with new regulations. | ERC Proof of... | € 150.000 | 2024 | Details |
Transforming Boron Chemistry By Exploring Boryl Radical Reactivity
This project aims to innovate organic chemistry by developing novel catalysis using boryl radicals for efficient C–B bond formation and new synthetic methods for complex molecules.
Electrochemical Borylation via Borylene Species: Bridging a Gap in Synthetic Chemistry
This project aims to utilize electrochemistry for the controlled generation of borylenes, enabling novel borylation techniques and unlocking access to previously inaccessible molecular structures.
Large-Scale Electrosynthesis of Borylated Azines
B-ELECTRO aims to develop scalable methods for synthesizing borylated azines for use in Suzuki-Miyaura cross-coupling, enhancing pharmaceutical and agrochemical innovation.
Reprogramming the reactivity of main-group compounds for capturing and activating methane and dinitrogen
The B-yond project aims to develop innovative main-group catalysts for unprecedented chemical transformations, advancing C-H bond functionalization and dinitrogen activation without transition metals.
Next Generation Chiral Fluorine Groups for Molecular Design
The project aims to develop sustainable fluorinated motifs using an organocatalytic platform to address environmental concerns while expanding chemical discovery in compliance with new regulations.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Unprecedented photolithographic structuring of novel light-sensitive poly(amino acid) materials– a paradigm shift in delivering biocompatible devicesPOLINA aims to revolutionize bioprinting and medical devices by combining innovative light-sensitive materials with advanced photolithography for improved tissue compatibility and drug discovery. | EIC Pathfinder | € 2.882.322 | 2024 | Details |
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy. | EIC Pathfinder | € 5.972.875 | 2024 | Details |
Unprecedented photolithographic structuring of novel light-sensitive poly(amino acid) materials– a paradigm shift in delivering biocompatible devices
POLINA aims to revolutionize bioprinting and medical devices by combining innovative light-sensitive materials with advanced photolithography for improved tissue compatibility and drug discovery.
Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis.
NuCapCure aims to develop novel cancer treatments for glioblastoma by utilizing custom-made drugs through biosynthesis to enhance proton and neutron therapies for better targeting and efficacy.